Tomohisa Akamatsu

Lectin-like oxidized low-density lipoprotein receptor-1 related microglial activation in neonatal hypoxic-ischemic encephalopathy: morphological consideration.

N. Kato, Takehiro Sugiyama, Yoshinori Aoki, 2021, The American journal of pathology.

Adapting pediatric health care responses to the COVID-19 pandemic in Japan: A clinical perspective.

H. Shichino, Keiji Goishi, H. Uryu, 2022, Global health & medicine.

A Pilot Study of Soluble Form of LOX‐1 as a Novel Biomarker for Neonatal Hypoxic‐Ischemic Encephalopathy

Masatoshi Kondo, Takehiro Sugiyama, Yoshinori Aoki, 2019, The Journal of pediatrics.

LOX-1 mediates inflammatory activation of microglial cells through the p38-MAPK/NF-κB pathways under hypoxic-ischemic conditions

A. Oka, Yoshinori Aoki, Naoto Takahashi, 2020, Cell Communication and Signaling.

LOX-1 (Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1) Deletion Has Protective Effects on Stroke in the Genetic Background of Stroke-Prone Spontaneously Hypertensive Rat

F. Takeuchi, N. Kato, T. Sawamura, 2020, Stroke.

LOX-1 is a novel therapeutic target in neonatal hypoxic-ischemic encephalopathy.

M. Mizuguchi, M. Itoh, A. Oka, 2014, The American journal of pathology.

LOX-1 mediates inflammatory activation of microglial cells through the p38-MAPK/NF-κB pathways under hypoxic-ischemic conditions

A. Oka, Yoshinori Aoki, Naoto Takahashi, 2023, Cell Communication and Signaling.